The enhancer/promoter of the vitellogenin II (VTG) gene has been extensively studied as a 29 model system of vertebrate transcriptional control. While deletion mutagenesis and in vivo 30 footprinting identified the transcription factor (TF) binding sites governing its tissue 31 specificity, DNase hypersensitivity-and DNA methylation studies revealed the epigenetic 32 changes accompanying its hormone-dependent activation. Moreover, upon induction with 33 estrogen (E 2 ), the region flanking the estrogen-responsive element (ERE) was reported to 34 undergo active DNA demethylation. We now show that although the VTG ERE is methylated 35 in embryonic chicken liver and in LMH/2A hepatocytes, its induction by E 2 was not 36 accompanied by extensive demethylation. In contrast, E 2 failed to activate a VTG 37 enhancer/promoter-controlled luciferase reporter gene methylated by SssI. Surprisingly, this 38 inducibility difference could be traced not to the ERE, but rather to a single CpG in an E-box 39 (CACGTG) sequence upstream of the VTG TATA box, which is unmethylated in vivo, but 40 methylated by SssI. We demonstrate that this E-box binds the upstream stimulating factor 41 USF1/2. Selective methylation of the CpG within this binding site with an E-box-specific 42 DNA methyltranferase Eco72IM was sufficient to attenuate USF1/2 binding in vitro and 43 abolish the hormone-induced transcription of the VTG gene in the reporter system.
INTRODUCTION 46
In vertebrates, the DNA methyltransferases DNMT1, DNMT3a and DNMT3b convert around 90% 47 9 substrate and even more efficiently in reactions containing the mC/mC oligo, but not the G 207 substrate. 208
In order to gain information regarding the substrate preference of Factor X, we carried out 209 an EMSA assay using eight oligonucleotide substrates carrying sequences flanking the ten CpGs in 210 the VTG enhancer/promoter ( Fig. 1A ; the two CpGs in the ERE were in a single duplex, as were 211
CpGs 5 and 6, because of their proximity). Because the sequence was reported by Saluz et al. 212 (Saluz et al., 1986) to be demethylated in a strand-specific manner, we also included 213 hemimethylated substrates. Surprisingly, in addition to oligos ERE and ΔG, Factor X bound also to 214 oligos containing CpG b/1, CpG a/2 and CpG7, but not CpG3, CpG4, CpG5-6 and CpG8 ( Fig. 2E  215 and Fig. S2F-H) . Moreover, its affinity for hemimethylated substrates varied, which suggested that 216 its sequence-and methylation specificity was unusually relaxed. 217
To characterize Factor X further, we carried out the EMSA assays with oligos containing 218 one BrdU residue on each strand (Fig. 3A , Table S2 ). Upon incubation with the NE, half of the 219 mixture was used for the EMSA experiment, while the other half was UV-crosslinked and the 220 proteins were then resolved by SDS-PAGE. During the cross-linking, the radiolabelled oligo 221 becomes covalently attached to the protein that binds it and the protein size can thus be estimated 222 from the position of the radioactive band on the SDS-PAGE, once the molecular weight of the oligo 223 is subtracted. As shown in Fig. 3B , the recombinant ERα-oligo complex migrated at the expected 224 size of ~80 kDa (lane 5) and a band of similar size was seen in LMH/2A NE cross-linked to the 225 C/C, mC/C or mC/mC substrates (lanes 1-4). In addition, a second, prominent band migrated at 226 around 50 kDa, irrespective of substrate. After subtracting the molecular weight of the single-227 stranded oligo (~15 kDa), the size of Factor X was predicted to be around 35-40 kDa. When the 228 recombinant receptor was titrated into the reaction with NE, we saw a weak, but reproducible, 229 competition with the smaller protein (Fig. 3C ). The ~80 kDa band could be outcompeted with a 230 specific (lane 8, spec), but not with an unspecific (lane 7, unspec) competitor, further confirming 231 that it was a complex of the oligo with ERα. The addition of E 2 did not alter the binding affinities or 232 ratios of the different proteins to the substrates (Fig. S3A ). The migration of the ERα band was also 233 unchanged in the presence of the hormone, confirming that the mobility shift seen in the EMSA 234 assay represented a conformational change of the receptor, which is eliminated upon denaturation. 235
Factor X is the E-box-binding heterodimer of upstream stimulating factors USF1/2. 237 We wanted to learn whether Factor X was a chicken-specific protein, or whether it was present also 238 in man. We therefore studied the binding properties of the eight oligonucleotide duplexes 239 containing the ten CpGs in the VTG enhancer/promoter (see above) in EMSA experiments using 240
NEs of the ER-positive breast cancer cell line MCF7 and the ER-negative cervical carcinoma 241 cell line HeLa. As shown in Fig. S3B ,C, the electrophoretic mobilities of the protein/DNA 242 complexes formed in HeLa (ERE, G, CpG4 and 7) and MCF7 (CpG4, 5-6, 7 and 8) extracts with 243 the indicated oligos were similar to those seen in LMH/2A extracts. We therefore assigned them to 244 Factor X. A distinct mobility shift was seen with oligo CpG3 (Fig. S2G ), but the CpG4, 5/6 and 8 245 substrates failed to form protein/DNA complexes ( Fig. 2E, Fig. S2H, Fig S3B,C) . Interestingly, 246 Factor X binding to the different oligos displayed distinct methylation sensitivities; thus, while its 247 binding to CpG2 was unaffected by methylation, the binding to oligos ERE, CpG1 and in particular 248 CpG7 was substantially attenuated by methylation ( Fig. 2 E) . The similarity of the proteins binding 249 the oligo substrates ERE and CpG7 was further confirmed in UV-crosslinking experiments (Fig. 250 S3D), thus implying that Factor X is a generic DNA binding protein with an ambiguous sequence-251 and methylation specificity. 252
In an attempt to identify Factor X, we subjected nuclear extracts of HeLa cells to affinity 253 chromatography. We first generated the DNA substrates by ligating the ERE (C/C or mC/mC), 254
CpG7 (C/C or mC/mC) or G oligonucleotide duplexes end-to-end so as to obtain molecules of 255 100-300 base pairs in length. The sticky ends were then filled-in with dATP and Bio-dUTP and the 256 tagged molecules were allowed to attach to streptavidin Dynabeads. We then preincubated HeLa described in Material and Methods. Following extensive washing, the bound proteins were eluted 259 with high salt and the tryptic digests were analysed by mass spectrometry (Fig. 4 A) . We searched 260 for peptide sequences present preferentially in the CpG7 and G but not in the methylated CpG7 261 elutions and originating from proteins with molecular size between 25 and 50 kDa. Beads-only and 262
CpG8 were used as negative controls. The peptides that fulfilled these exclusion criteria to the 263 greatest extent were the TFs DEC1, MAX, MLX, Myc, USF1 and USF2, firstly because they were 264 identified with elevated frequencies (Table 1 ) and, second, because their preferred recognition 265 sequences overlapped to a large extent with those of our affinity probes. 266
We immunodepleted HeLa nuclear extracts with antibodies against these possible Factor X 267 candidates and performed EMSA assays. The USF1-or USF2-immunodepleted extracts ( Fig. S4A ) 268 largely lost the ability to bind the CpG7 and G duplexes and the fraction of the shifted oligos in 269 the USF2-depleted extracts was clearly reduced ( Fig 4B) . The same could be shown with the 270 unmethylated-and methylated ERE substrates ( Fig. S4B ). For a direct comparison, Fig. S4C shows 271 an EMSA experiment in which the four oligo substrates were incubated with the USF1-depleted 272 and IgG-depleted (negative control) extracts. To confirm the depletion specificity, we performed 273
EMSAs with HeLa NE that were pre-incubated with antibodies raised against the above proteins. 274
As shown in Fig. 4C , the antibody against USF1 caused a supershift of the complex, while the 275 antibody against USF2 attenuated the binding of Factor X to the two duplexes. To confirm the 276 specificity of the depletion further, we carried out a UV-crosslinking experiment with the USF1-or 277 USF2-depleted extracts, as well as with proteins eluted from the beads with high salt. The effect of 278 the depletion was not very pronounced ( Fig. 4D, lanes 1-4) , probably because EMSA assays detect 279 complexes with relatively long life times, whereas UV-cross-links even transient complexes. 280
However, a band corresponding in size to Factor X was present in the eluates from the USF1 and 281 USF2 beads, but not from the control, IgG beads ( Fig. 4D ). This evidence strongly suggests that 282 Factor X is a heterodimer of USF1 and USF2, which is known to be methylation-sensitive (Chen et  283 that brought about a demethylation of the ERE and the downstream sequences, and that this 294 demethylation was a prerequisite for transcriptional activation. However, in our in vivo system, 295 induction of VTG transcription with E 2 did not require demethylation ( Fig. 1C and Fig S1F) . We 296 therefore had to consider the possibility that the gene was silent in rooster only because of the lack 297 of the hormone and that its methylation was simply a mark of inactive chromatin. In order to 298 elucidate this phenomenon, we generated a reporter vector based on the CpG-free pCpGL-basic 299 plasmid, in which the luciferase gene is driven by the VTG enhancer/promoter. We first introduced 300 into the VTG sequence unique KpnI and HindIII sites on either side of the ERE and then ligated this 301 enhancer/promoter into pCpGL-basic to generate VTG-CpGL ( Fig S5A) . Upon transfection of this 302 reporter into LMH/2A cells, luciferase expression could be efficiently induced with E 2 (Fig 5A,  303 ERE). Convertion of the wild type ERE sequence to G by site-directed mutagenesis resulted in 304 similar levels of basal transcription, but substantially lower inducibility ( Fig. 5A) , caused by the 305 significantly lower affinity of ER for the G ERE lacking the spacer deoxyguanosine ( Fig. 2B,C) . 306
In vitro methylation of these two reporters with SssI largely abolished transcriptional inducibility binding of ER is unaffected by methylation and shows that its transcriptional activity is also 311 methylation-independent. (Hydroxymethylation was included, because we detected low levels of 312 this modification in the in vivo activation experiments shown in Fig. S1F .) 313
Having shown that methylation of the ten CpGs in the VTG enhancer/promoter by SssI 314 substantially attenuated E 2 inducibility of the reporter (Fig. 5A ), but that methylation of the ERE 315 was without effect (Fig. 5B ), we wanted to learn which CpGs were responsible for the 316 transcriptional silencing. We therefore converted CpGs 1-8 ( Fig. 1A) to TpGs by site-directed 317 mutagensis. We could show that the C to T transition mutations at CpGs 1-6 and 8 failed to affect 318 the basal transcriptional activity of the reporter and reduce its inducibility by E 2 . Indeed, the 319 inducibility was increased in some cases ( Fig. S5B ). In contrast, C to T mutations in CpGs c and d 320 in the ERE (mut ERE) and CpG7 (C594T) attenuated the inducibility upon E 2 treatment ( Fig.  321 S5B,C). To learn whether the mutation in CpG7 affected USF1/2 binding, we tested the mutant 322 oligo in an EMSA assay and found that the affinity of the protein for the mutated sequence was 323 intermediate between that of the wt unmethylated CpG7 duplex and the methylated one ( Fig. S5D) . 324
This translated directly to luciferase expression, where the mutant CpG7 (C594T) showed 325 intermediate expression between the wt mock-methylated (wt C) and SssI-methylated (wt mC) 326 reporters ( Fig. S5B ). The expression of all the mutant reporters was inhibited upon methylation 327
with SssI, showing that the individual sites had no major influence on transcription of the reporter, 328 irrespective of whether they were methylated or unmethylated ( Fig. S5E ). 329
In order to exclude the role of CpG1-6 and 8 in the transcriptional regulation of the VTG 330 enhancer/promoter, we mutated them sequentially, such that the final mutant contained only CpG c 331 and d in the ERE and CpG7. We tested the single and multiple mutants to exclude the possibility 332 that interactions between different sites had additional influence on transcription, but this was not 333 the case. All combinations tested were active when unmethylated and inhibited when methylated 334 with SssI (data not shown). Analysis of the final plasmid (ERE/7 wt) unmethylated and methylated 335 confirmed that the silencing of the VTG enhancer/promoter was mediated by methylation of CpG7 336
In order to demonstrate the key importance of CpG7 in the control of VTG transcription, we 339 methylated the wt reporter with Eco72I methylase (Rimseliene et al., 1995), which modifies solely 340 the CACGTG E-box sequence. As shown in Fig. 5D , methylation of this site substantially 341 attenuated basal luciferase expression, as well as its inducibility by E 2 , if not to the same extent as 342 modification of all ten CpG sites by SssI methylase. In contrast, methylation of the reporter with 343
HpaII methylase, which modifies CpG d in the ERE, had no appreciable effect on luciferase 344 expression. 345
In a converse experiment, we wanted to reproduce the methylation pattern seen in the 346 chicken embryo and in LMH/2A cells. To this end, we cleaved the reporter vector with PmlI, which 347 cuts the E-box sequence and, as control, with HpaII that cuts the ERE or XmnI that cuts the vector 348 backbone. We then methylated the linear DNA with SssI and recircularised it with T4 DNA ligase. 349
In the PmlI-cut vector, all CpGs with the exception of CpG7 were methylated, whereas only the was treated with SssI without prior cleavage (undigested) were refractory to induction with E 2 . 355
Finally, we wanted to confirm that the transcriptional control of VTG expression rests not 356 only with CpG7, but also with the protein that binds the E-box: USF1/2. We therefore knocked 357 down USF1 or luciferase (control) with siRNA ( Fig resistant to bisulphite conversion in our experimental systems, however, we were able to detect low 374 levels of the TET oxidation product hmC already 6 hours after E 2 treatment that increased further 375 with longer exposure to E 2 . The TET enzymes and TDG are present in both chicken embryonic and 376 adult liver, as well as in the LMH2A cell line (data not shown), and it is therefore possible that the 377 hormone-activated VTG gene is indeed targeted for demethylation, but that, unlike in the rooster, 378 the demethylation machinery in our experimental set-up is not fully-functional. The finding that 379 hmC proportion increased at the four CpGs upon hormone treatment at longer time points and that 380 VTG induction was higher upon TET2 overexpression (data not shown) implied that the 381 demethylation machinery can act on the VTG locus and that it has a positive effect on transcription. 382
This could be further confirmed in cells treated with 5-azadeoxycytidine prior to induction with E 2 . 383
In these cells, VTG expression was several-fold higher than even in the TET2-overexpressing cells 384 (data not shown). 385
Puzzlingly, we failed to find evidence of hmC oxidation to fC or caC, steps necessary for 386 the TDG-initiated base excision repair process that completes the multistep demethylation process. 387
It is conceivable that the TET-mediated cascade terminated in our system after a single oxidation 388 , 1982) . Another possibility is that fC and caC excision and the subsequent BER 391 steps were extremely rapid and were followed by immediate remethylation. Although such cyclic 392 DNA demethylation/methylation events have been described in the pS2 promoter upon hormone 393 treatment, it is unlikely that this was so in our system, because the cycling process supresses 394 transcription (Kangaspeska et al., 2008; Metivier et al., 2008) . 395
Although the above phenomenon requires further study, our data demonstrate that while 396 global DNA demethylation facilitates transcription of the endogenous VTG gene upon hormone 397 activation, site-specific demethylation of the ERE region is clearly not necessary. This agrees with 398 our in vitro data ( Fig. 2B) showing that the ER binding to the ERE was unaffected by methylation. 399
Indeed, the hormone-activated receptor needs to be able to bind to its cognate sequence irrespective 400 of its methylation status, in order to recruit the chromatin-remodelling-and possibly also the 401 demethylation machinery that are needed to facilitate transcription. 402
Given the requirement for ERα binding in E 2 -dependent VTG activation, the weak 403 inducibility of the ΔG ERE reporter was puzzling, because the ΔG oligonucleotide did not 404 detectably bind the receptor in vitro (Fig. 2B , C). However, it is possible that the observed 405 induction was mediated by a second, imperfect ERE sequence, which lies around position -350 406 from the transcription start site ( Fig. 1A) . 407
As mentioned in the Introduction, the VTG enhancer/promoter has been studied extensively 408 in the past and it could be shown that it contains several TF binding sites that control its basal-and 409 liver-specific transcription, as well as its hormone-inducibility. Linker-scanning mutagenesis (Seal 410 et al., 1991) revealed that deletion of the sequence between -113 and -335 eliminated the hepatocyte 411 specificity, permitting the reporter contruct to be expressed also in fibroblasts. Importantly, 412 insertion of a linker around position -50 abolished estrogen inducibility of the reporter. This 413 mutation disrupted the E-box sequence, which contains CpG7 identified in this study as being 414 critical for hormone induction of the silenced gene. Clearly, the interaction of the E-box binding 415 factor (in our case the USF1/2 heterodimer) with the estrogen receptor is essential for hormone 416 activation, given that mutational inactivation (Seal et al., 1991) or methylation (this study) of the E-417 box attenuates USF1/2 binding in vitro and the inducibility of the gene in vivo, as does mutation 418 (but not methylation) of the ERE (Fig. S5B, C) . 419
The interaction of different TF combinations bound at promoters and enhancers potentially 420 This could explain why the C to T mutation in CpG7 had such a deleterious effect on estrogen 432 inducibility ( Fig. S5B, C) . However, it does not explain why the factor bound so efficiently to the 433 different sequences in our EMSA assays ( Fig. 2D,E; Fig. S2F,G,H) . Similarly, methylation of the 434 E-box sequence would also lower the E 2 inducibility of the VTG enhancer/promoter, because the 435 affinity of USF1/2 for the methylated sequence is low (Fig. 2D, E ). As noted above, however, there 436 are a number of TFs that could potentially bind to the E-box in the absence of USF1/2 and activate 437 VTG transcription, particularly as somenotably c-Mychave been reported to interact with ER 438 (Cheng et al., 2006) . These questions require clarification in the future, as does the reason why the 439 VTG E-box sequence is the only CpG site out of the ten that remains unmethylated in vivo. It is possible that its methylation is actively prevented, possibly due to the fact that it is rapidly bound by 441 USF1/2 or other E-box proteins and thus that the access of methyl transferases to this site is 442 hindered. This has been proposed as a possible mechanism that protects CpG islands from de novo Anti-USF1 (GeneTex GTX16396), mouse Anti-USF2 (Santa Cruz, sc-293443). 505
Chromatin immunoprecipitation 521 75 Mio LMH/2A cells were harvested after 24 hours treatment with 100 nM E 2 or EtOH. Cells 522 were washed twice with PBS and fixed for 10 min in 1% formaldehyde at RT. Fixation was 523 quenched with 125 mM glycine at RT for 10 min. Cells were collected by centrifugation at 300 x g 524 for 5 min at 4°C, washed twice with PBS and the pellet was resuspended in cell lysis buffer (10 mM 525 Tris, pH 8, 1 mM EDTA, 0.5% IGEPAL, protease inhibitors) and incubated on ice for 10 min. The 526 lysate was centrifuged at 2'000 x g at 4°C for 5 min. The pellet was resuspended in nuclear lysis 527 buffer (10 mM Tris, pH 8, 1 mM EDTA, 0.5 M NaCl, 1% Triton X-100, 0.5% sodium 528 deoxycholate, 0.5% lauroylsarcosine, protease inhibitors) and incubated on ice for 10 min with 529 repeated vortexing. Lysate was centrifuged at 3'000 x g for 5 min at 4°C. The pellet was 530 resuspended in PBS, split for different immunoprecipitations and centrifuged at 3'000 x g for 10 531 min at 4°C. Pellets were resuspended in 300 µl lysis buffer (10 mM Tris, pH 8, 1 mM EDTA, 150 532 mM NaCl, 0.1% sodium deoxycholate, 0.1% SDS, protease inhibitors) and sonicated at maximum 533 power for 10 min with 30 s intervals in a Bioruptor (Diagnode). Samples were centrifuged at 16'000 534
x g for 10 min at 4°C and the supernatant was collected. Input samples (15%) were frozen and the 535 rest was made up to 1 ml with IP buffer (16.7 mM Tris, pH 8, 1.2 mM EDTA, 300 mM NaCl, 1.1% 536 Triton X-100, protease inhibitors). 5 µg of the respective antibodies (Anti-ERα; ThermoFisher 537 MA5-13065 or Anti-Flag; Sigma F3165) were added to the lysate and incubated on a rotating wheel 538 at 4°C overnight. 539
The beads (G protein Sepharose, GE Healthcare) were washed twice in IP buffer and centrifuged 540 for 2 min at 2'700 x g before blocking with 1 mg/ml BSA in IP buffer for 1 h. After one additional 541 wash, 50 µl of beads were added to 1 ml lysate with the antibody. The mixture was incubated for 3 542 hours on a rotating wheel at 4°C. Mixtures were centrifuged for 2 min at 2'000 x g and the buffers for 5 min on the rotating wheel (wash buffer 1: 20 mM Tris, pH 8, 2 mM EDTA, 0.1% SDS, 545 1% Triton X-100, 300 mM NaCl; wash buffer 2: like wash buffer 1, but with 500 mM NaCl; wash 546 buffer 3: 10 mM Tris, pH 8, 1 mM EDTA, 1% sodium deoxycholate, 500 mM LiCl, 1% NP-40; 547 wash buffer 4: 10 mM Tris, pH 8, 1 mM EDTA). One additional wash with wash buffer 4 was 548 performed, during which the beads were divided for DNA and proteins. For proteins: the beads 549 were taken up in 2x SDS loading dye (100 mM Tris, pH 6.8, 20% glycerol, 3.2% SDS, 0.2 mM 550 DTT, 0.04% bromophenol blue), the mixture was vortexed vigorously and incubated for 30 min at 551 100°C (denaturing and de-cross-linking). The beads were spun down and the supernatant was 552 loaded on an SDS-PAGE together with inputs. Gels were processed further according to general 553 WB protocol. For DNA: beads and inputs were taken up in 100 µl crosslink reversal buffer (20 mM 554 Tris, pH 8, 0.5 mM EDTA, 0.1 M NaHCO 3 , 1% SDS, RNase at 10 µg/ml (Roche)) and incubated at 555 in Table S1 (SI). The forward primers were only added after the first 5 cycles to reduce the on a 2% agarose gel according to manufacturer's instructions, before being bar-coded for PacBio 726 sequencing. 727 728 729 730
PacBio sequencing and analysis 731
The PacBio single-molecule real-time (SMRT) sequencing technology works by a strand-732 displacement mechanism on circularised single molecules. The highly-processive polymerase 733 copies the circle multiple times to generate a long read containing many repeats of the same 734 sequence. The deconvolution to single reads generates a consensus sequence that corrects the high 735 error-rate of the polymerase, resulting thus in very accurate sequencing results. The sequencing and 736 data evaluation were carried out in collaboration with the Functional Genomic Center Zurich 737 (www.fgcz.ch). 738 739 Affinity purification and mass spectrometry 740 Different CpG-containing oligonucleotides with 5'-TTAA overhangs were annealed and end-to-end 741 ligated overnight at 16°C with T4 ligase (NEB). Oligos were ethanol-precipitated and filled-in with 742 1 mM biotinylated dUTP (Thermo Fisher) using Klenow fragment (NEB). Reactions were passed 743 twice through a Sephadex G-25 desalting column (GE Healthcare) to get rid to free dUTP and 744 subsequently bound to Dynabeads M-280 Streptavidin (Invitrogen) by rotating 20 min at RT. 745 1.5 mg of nuclear extracts were pre-incubated with 30 µg of poly(dI-dC), before an equal volume 746 was added to the beads. Binding was allowed to take place in 1x EMSA buffer without BSA for 30 747 min on a rotating wheel at 4 °C. Beads were washed 2x with 60 µl 1x EMSA buffer without BSA. 748
Bound proteins were eluted with 60 µl of elution buffer (10 mM Tris-HCl pH 7.6, 5 % glycerol, 1M 749 NaCl) 30 min rotating at 4°C. Elution was desalted on 0.025 µm VSWP membranes (Merck) 750 against water for EMSAs. 751
Shotgun LC-MS/MS 753
The protein mixture was digested with trypsin. After cleaning up, the peptide mixture was applied 754 to a reversed phase high-performance liquid chromatography (HPLC) column and separated prior to 755 ionization and analysis by the mass spectrometer. The peptide ions selected by an instrument 756 algorithm for fragmentation were recorded as a peptide signature, which was analyzed by a 757 sequence algorithm (MASCOT). The peptides were scored according to the average probability 758 using total spectra counts. The complete list of the MS results can be found online in 759 1  69  70  138  207  276  345  414   TTCATTTAAAAATATTCCTGGTCAGCGTGACCGGAGCTGAAAGAACACATTGATCCCGTGATTTCAATA  AATACATATGTTCCATATATTGTTTCTCAGTAGCCTCTTAAATCATGTGCGTTGGTGCACATATGAATA  CATGAATAGCAAAGGTTTATCTGGATTAGCCTCTGGCCTGCAGGAATGGCCATAAACCAAAGCTGAGGG  AAGAGGGAGAGTATAGTCAATGTAGATTATACTGATTGCTGATTGGGTTATTATCAGCTAGATAACAAC  TTGGGTCAGGTGCCAGGTCAACATAACCTGGGCAAAACCAGTCTCATCTGTGGCAGGACCATGTACCAG  CAGCCAGCCGTGACCCAATCTAGGAAAGCAAGTAGCACATCAATTTTAAATTTATTGTAAATGCCGTAG  TAGAAGTGTTTTACTGTGATACATTGAAACTTCTGGTCAATCAGAAAAAGGTTTTTTATCAGAGATGCC  AAGGTATTATTTGATTTTCTTTATTCGCCGTGAAGAGAATTTATGATTGCAAAAAGAGGAGTGTTTACA  TAAACTGATAAAAAACTTGAGAATTCAGCAGAAAACAGCCACGTGTTCCTGAACATTCTTCCATAAAAG  TCTCACCATGCCTGGCAGAGCCCTATTCACCTTCGCTATG   483  552  621  661   139  208  277  346  415  484  553 
